RadNet, Inc.
General ticker "RDNT" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $4.7B (TTM average)
RadNet, Inc. follows the US Stock Market performance with the rate: 66.4%.
Estimated limits based on current volatility of 2.9%: low 68.57$, high 72.66$
Factors to consider:
- Total employees count: 8546 (+8.6%) as of 2024
- US accounted for 98.5% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Economic downturns and volatility, Inflationary pressures, Pandemic risks, Operational and conduct risks, Cybersecurity threats
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [58.57$, 93.68$]
- 2025-12-31 to 2026-12-31 estimated range: [54.52$, 89.55$]
Financial Metrics affecting the RDNT estimates:
- Negative: with PPE of 114.9 at the end of fiscal year the price was high
- Positive: -4.75 < Operating profit margin, % of 5.72
- Positive: -4.43 < Investing cash flow per share per price, % of -4.41
- Positive: 19.40 < Shareholder equity ratio, % of 27.45 <= 42.68
- Positive: Interest expense per share per price, % of 1.51 <= 3.28
- Positive: Inventory ratio change, % of 0.11 <= 0.80
- Positive: Industry inventory ratio change (median), % of -0.93 <= -0.16
- Positive: -3.43 < Return on assets ratio (scaled to [-100,100]) of 1.17
Short-term RDNT quotes
Long-term RDNT plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1,430.06MM | $1,616.63MM | $1,829.66MM |
| Operating Expenses | $1,383.70MM | $1,517.93MM | $1,725.04MM |
| Operating Income | $46.36MM | $98.70MM | $104.62MM |
| Non-Operating Income | $-3.39MM | $-59.89MM | $-59.76MM |
| Interest Expense | $50.84MM | $64.48MM | $79.85MM |
| Income(Loss) | $42.97MM | $38.81MM | $44.86MM |
| Taxes | $9.36MM | $8.47MM | $6.03MM |
| Profit(Loss)* | $10.65MM | $3.04MM | $2.79MM |
| Stockholders Equity | $333.00MM | $630.70MM | $902.31MM |
| Assets | $2,433.91MM | $2,690.47MM | $3,286.69MM |
| Operating Cash Flow | $146.42MM | $220.86MM | $233.02MM |
| Capital expenditure | $249.41MM | $176.60MM | $188.07MM |
| Investing Cash Flow | $-246.95MM | $-201.47MM | $-233.07MM |
| Financing Cash Flow | $93.65MM | $195.63MM | $397.95MM |
| Earnings Per Share** | $0.19 | $0.05 | $0.04 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.